Sonnet BioTherapeutics Holdings Inc News - SONN | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Sonnet BioTherapeutics Holdings Inc (SONN)
Sonnet BioTherapeutics Holdings Inc (SONN) News

Sonnet BioTherapeutics Holdings Inc (SONN)

1.42

-0.02

(-1.39%)

Closed December 25 3:00PM

Delayed by 15 minutes

1.42

0.00

(0.00%)

After Hours: 2:59PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Sonnet BioTherapeutics Announces Publication Detailing the Discovery and Development of SON-1010, an Albumin-Binding IL-12 Fusion Protein, Demonstrating Its Mechanism of Action

Pankaj Mohan, CEO of Sonnet discusses what this publication means in a Virtual Investor “What This Means”...

Form S-8 - Securities to be offered to employees in employee benefit plans

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment

Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S...

Form 8-K - Current report

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

1
2
Next

tw0122

tw0122 2 weeks ago

Cash out time 5.45 + 150%

LowFloatLopes

LowFloatLopes 2 weeks ago

I'm at $2.50 out at $4.50 in less than 8 mins lol

tw0122

tw0122 2 weeks ago

Don't stay in long this one hardly ever stays up high long 3.49 +'80%

Monksdream

Monksdream 2 weeks ago

SONN, 10Q due DEC 13

tw0122

tw0122 2 months ago

Reverse split was September

Invest-in-America

Invest-in-America 2 months ago

SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)

Tiger Money

Tiger Money 2 months ago

What is going on here? Reverse? Where is the float on this train wreck now?

bigfart

bigfart 2 months ago

So insiders can dump before the RS

tw0122

tw0122 2 months ago

Reverse split offering and now some news $8s

tw0122

tw0122 3 months ago

May the reverse split gods come soon. Keep an eye!

BooDog

BooDog 3 months ago

Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html

Clemdane

Clemdane 4 months ago

Big jump today!

Awl416

Awl416 4 months ago

Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer

Monksdream

Monksdream 4 months ago

SONN new 52=low

Clemdane

Clemdane 4 months ago

Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.

Monksdream

Monksdream 4 months ago

SONN new 52 week low

Monksdream

Monksdream 4 months ago

SONN new 52 week low

Monksdream

Monksdream 6 months ago

SONN new 52 week low

Monksdream

Monksdream 6 months ago

SONN new 52 week low

BooDog

BooDog 8 months ago

I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.

maq1214

maq1214 9 months ago

Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !

81vette

81vette 9 months ago

23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this

81vette

81vette 9 months ago

They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising

maq1214

maq1214 9 months ago

Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot

81vette

81vette 9 months ago

$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now

81vette

81vette 9 months ago

254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading

81vette

81vette 9 months ago

5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m

BooDog

BooDog 9 months ago

Riding free again.

Monksdream

Monksdream 10 months ago

crowin

crowin 10 months ago

Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30

maq1214

maq1214 10 months ago

This should get exciting soon, crazy volume yesterday !

BooDog

BooDog 11 months ago

IS it just greed or might this make good for another round trip? We'll see next week.

BooDog

BooDog 12 months ago

Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report

Monksdream

Monksdream 1 year ago

SONN new 52 week low

BooDog

BooDog 1 year ago

Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208

valleybenedetto

valleybenedetto 1 year ago

Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now

Monksdream

Monksdream 1 year ago

SONN new 52 week low

Monksdream

Monksdream 1 year ago

SONN new 52 week low

Monksdream

Monksdream 1 year ago

SONN new 52 week low

Monksdream

Monksdream 1 year ago

SONN new 52 week low

valleybenedetto

valleybenedetto 1 year ago

If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.

Monksdream

Monksdream 1 year ago

If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it

valleybenedetto

valleybenedetto 1 year ago

You worry about you ok?

Monksdream

Monksdream 1 year ago

You aren’t getting any money back
Time to move on

valleybenedetto

valleybenedetto 1 year ago

Not an Urban Myth ..I've already checked. They have current D and O insurance.

Monksdream

Monksdream 1 year ago

Oh goddamn tell me another urban myth

valleybenedetto

valleybenedetto 1 year ago

They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know

Monksdream

Monksdream 1 year ago

You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago

valleybenedetto

valleybenedetto 1 year ago

CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.

Monksdream

Monksdream 1 year ago

SONN new 52 week low

Sonnet BioTherapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions